2019 is the worst year for Johnson & Johnson (NYSE:JNJ). The company is ordered to pay $8 billion in punitive damages by the jury after it failed to warn the young boy over the side effects of an anti-psychoactive drug – Risperdal. According to the filing, Johnson & Johnson has pushed the doctors to prescribe […]
Sign Up To Get Our Instant Alerts!
- Antitrust Decision May Stand In The Way Of Amazon.com, Inc (NASDAQ:AMZN) Making Acquisitions 38 views
- Ford Motor (NYSE:F) To Utilize Mcdonald’s Waste In Manufacturing Activities 31 views
- Facebook Inc (NASDAQ:FB) Faces Pressure In Line With Its Plan To Encrypt Its Messaging 25 views
- Facebook, Inc. (NASDAQ:FB) Fails To Win The Bid For Fitbit: Facebook’s Is Unsuccessful To Establish A Position In Health Tech And Wearables Markets 23 views
- Facebook’s (NASDAQ:FB) CEO Says Breaking Up The Company Won’t Fix Political Discourse 20 views